- Home
- ATAI vs THW Comparison
ATAI vs THW Comparison
Compare ATAI & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- THW
- Stock Information
- Founded
- ATAI 2018
- THW 2015
- Country
- ATAI Germany
- THW United States
- Employees
- ATAI N/A
- THW N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- ATAI Health Care
- THW Finance
- Exchange
- ATAI Nasdaq
- THW Nasdaq
- Market Cap
- ATAI 444.7M
- THW 391.1M
- IPO Year
- ATAI 2021
- THW N/A
- Fundamental
- Price
- ATAI $3.85
- THW $10.99
- Analyst Decision
- ATAI Strong Buy
- THW
- Analyst Count
- ATAI 3
- THW 0
- Target Price
- ATAI $13.33
- THW N/A
- AVG Volume (30 Days)
- ATAI 6.6M
- THW 149.9K
- Earning Date
- ATAI 08-12-2025
- THW 01-01-0001
- Dividend Yield
- ATAI N/A
- THW 10.76%
- EPS Growth
- ATAI N/A
- THW N/A
- EPS
- ATAI N/A
- THW N/A
- Revenue
- ATAI $1,863,000.00
- THW N/A
- Revenue This Year
- ATAI $423.05
- THW N/A
- Revenue Next Year
- ATAI N/A
- THW N/A
- P/E Ratio
- ATAI N/A
- THW N/A
- Revenue Growth
- ATAI 572.56
- THW N/A
- 52 Week Low
- ATAI $1.03
- THW $9.76
- 52 Week High
- ATAI $4.00
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- ATAI 69.83
- THW 60.73
- Support Level
- ATAI $3.06
- THW $10.94
- Resistance Level
- ATAI $3.70
- THW $11.11
- Average True Range (ATR)
- ATAI 0.28
- THW 0.20
- MACD
- ATAI 0.03
- THW 0.07
- Stochastic Oscillator
- ATAI 89.08
- THW 73.19
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.